These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2608070)

  • 21. Activation of human thymocytes by antibodies to the CD3/T-cell receptor complex: triggering of different epitopes results in different signals.
    Schwinzer R; Sommermeyer H; Schlitt HJ; Schmidt RE; Wonigeit K
    Cell Immunol; 1991 Sep; 136(2):318-28. PubMed ID: 1714794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation by anti-CD2 monoclonal antibody of the activation of a human T cell clone induced by anti-CD3 or anti-T cell receptor antibodies.
    Yssel H; Aubry JP; de Waal Malefijt R; de Vries JE; Spits H
    J Immunol; 1987 Nov; 139(9):2850-5. PubMed ID: 2444643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human cytolytic cell clones lacking surface expression of T cell receptor alpha/beta or gamma/delta. Evidence that surface structures other than CD3 or CD2 molecules are required for signal transduction.
    Pantaleo G; Zocchi MR; Ferrini S; Poggi A; Tambussi G; Bottino C; Moretta L; Moretta A
    J Exp Med; 1988 Jul; 168(1):13-24. PubMed ID: 3260936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequential cooperation of CD2 and CD48 in the buildup of the early TCR signalosome.
    Muhammad A; Schiller HB; Forster F; Eckerstorfer P; Geyeregger R; Leksa V; Zlabinger GJ; Sibilia M; Sonnleitner A; Paster W; Stockinger H
    J Immunol; 2009 Jun; 182(12):7672-80. PubMed ID: 19494291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulation of MAP-2 kinase activity in T lymphocytes by anti-CD3 or anti-Ti monoclonal antibody is partially dependent on protein kinase C.
    Nel AE; Hanekom C; Rheeder A; Williams K; Pollack S; Katz R; Landreth GE
    J Immunol; 1990 Apr; 144(7):2683-9. PubMed ID: 2156931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The CD3 zeta cytoplasmic domain mediates CD2-induced T cell activation.
    Howard FD; Moingeon P; Moebius U; McConkey DJ; Yandava B; Gennert TE; Reinherz EL
    J Exp Med; 1992 Jul; 176(1):139-45. PubMed ID: 1351920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the T-cell activation signaling pathway mediated by tyrosine kinases, protein kinase C, and Ras protein, which is modulated by intracellular cyclic AMP.
    Ohtsuka T; Kaziro Y; Satoh T
    Biochim Biophys Acta; 1996 Feb; 1310(2):223-32. PubMed ID: 8611637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD3 zeta dependence of the CD2 pathway of activation in T lymphocytes and natural killer cells.
    Moingeon P; Lucich JL; McConkey DJ; Letourneur F; Malissen B; Kochan J; Chang HC; Rodewald HR; Reinherz EL
    Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1492-6. PubMed ID: 1346934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased intracellular cyclic AMP inhibits inositol phospholipid hydrolysis induced by perturbation of the T cell receptor/CD3 complex but not by G-protein stimulation. Association with protein kinase A-mediated phosphorylation of phospholipase C-gamma 1.
    Alava MA; DeBell KE; Conti A; Hoffman T; Bonvini E
    Biochem J; 1992 May; 284 ( Pt 1)(Pt 1):189-99. PubMed ID: 1318020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD3 and CD2 ligation alters CD49d epitope expression.
    Lin J; Qin L; Chavin KD; Ding Y; Punch JD; Yang Q; Burkly LC; Bromberg JS
    Pathobiology; 1995; 63(3):119-32. PubMed ID: 8821628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulation through the TCR/CD3 complex up-regulates the CD2 surface expression on human T lymphocytes.
    Alberola-Ila J; Places L; de la Calle O; Romero M; Yagüe J; Gallart T; Vives J; Lozano F
    J Immunol; 1991 Feb; 146(4):1085-92. PubMed ID: 1671400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD2 can mediate TCR/CD3-independent T cell activation.
    Ohno H; Ushiyama C; Taniguchi M; Germain RN; Saito T
    J Immunol; 1991 Jun; 146(11):3742-6. PubMed ID: 1674520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human T cell activation: differential response to anti-CD28 as compared to anti-CD3 monoclonal antibodies.
    Bjorndahl JM; Sung SS; Hansen JA; Fu SM
    Eur J Immunol; 1989 May; 19(5):881-7. PubMed ID: 2544432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T cell receptor-independent CD2 signal transduction in FcR+ cells.
    Arulanandam AR; Koyasu S; Reinherz EL
    J Exp Med; 1991 Apr; 173(4):859-68. PubMed ID: 1706751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta.
    Moretta A; Poggi A; Pende D; Tripodi G; Orengo AM; Pella N; Augugliaro R; Bottino C; Ciccone E; Moretta L
    J Exp Med; 1991 Dec; 174(6):1393-8. PubMed ID: 1720808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of interleukin-2 production and phosphatidylserine synthesis in Jurkat T lymphocytes by K+ channel antagonists.
    Aussel C; Pelassy C; Mary D; Choquet D; Rossi B
    Immunopharmacology; 1990; 20(2):97-103. PubMed ID: 2266004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD2/LFA-3 ligation induces phospholipase-C gamma 1 tyrosine phosphorylation and regulates CD3 signaling.
    Kanner SB; Damle NK; Blake J; Aruffo A; Ledbetter JA
    J Immunol; 1992 Apr; 148(7):2023-9. PubMed ID: 1372020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T-cell activation. V. Anti-major histocompatibility complex class I antibody-induced activation and clonal abortion in Jurkat T-leukaemic cells.
    Claesson MH; Dissing S; Tscherning T; Geisler C
    Immunology; 1993 Mar; 78(3):444-8. PubMed ID: 8097490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclic AMP- and inositol phosphate-independent inhibition of Ca2+ influx by cholera toxin in CD3-stimulated Jurkat T cells. A study with a cholera toxin-resistant cell variant and the Ca2+ endoplasmic reticulum-ATPase inhibitor thapsigargin.
    Gouy H; Cefai D; Christensen SB; Debre P; Bismuth G
    J Immunol; 1991 Aug; 147(3):757-66. PubMed ID: 1650386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A common pathway for T lymphocyte activation involving both the CD3-Ti complex and CD2 sheep erythrocyte receptor determinants.
    Yang SY; Chouaib S; Dupont B
    J Immunol; 1986 Aug; 137(4):1097-100. PubMed ID: 2426350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.